Tag: neurovascular

CorPath GRX Corindus

Corindus announces regulatory approval of CorPath GRX for neurovascular intervention in...

Corindus Vascular Robotics has announced that it received approval from the Australian Therapeutic Goods Administration to commercialise its CorPath GRX System for neurovascular interventions...

Vesalio reports expansion of international distributor network and Stroke Congress Exhibition...

Vesalio has announced that it has executed multiple exclusive distribution agreements in Europe, Latin America, Asia and the Middle East and now has market...

Physicians’ Education Resource to host first annual International Congress on the...

Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), will host the first annual International Congress on the Future of...

Corindus announces FDA submission for neurovascular intervention indication for CorPath GRX

Corindus Vascular Robotics announces that it is seeking premarket clearance from the US Food and Drug Administration (FDA) to use the CorPath GRX System...

Are drug-coated balloons and drug-eluting stents the future in intracranial atherosclerotic...

Alternative treatment options for patients with intracranial atherosclerotic disease (ICAD) are needed, given its prevalence worldwide and the associated risk of recurrent ischaemic events....

Favourable revascularisation rates for first-in-man results of the Versi Retriever in...

First-in-man results of the Versi Retriever (NeuroVasc Technologies) in acute ischaemic stroke patients with large vessel occlusions demonstrate a promising safety profile and efficacious...

Cerenovus launches largest global registry to study stroke-inducing blood clots removed...

Johnson & Johnson has announced that its Cerenovus business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyse stroke-inducing...